anti-LPL antibody product blog
Tags: Antibody; LPL; Monoclonal Antibody; anti-LPL antibody;
The LPL lpl (Catalog #MBS475904) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The Anti-LPL Mouse mAb reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s LPL can be used in a range of immunoassay formats including, but not limited to, Western Blot (WB). Researchers should empirically determine the suitability of the LPL lpl for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.The LPL lpl product has the following accession number(s) (GI #48146225) (NCBI Accession #CAG33335.1). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the Anti-LPL Mouse mAb with the following immunoassay(s):
Western Blot (WB) (Western blot analysis using LPL mouse mAb against Hela cell lysate (1).)
Entrez Summary: LPL: lipoprotein lipase, also known as LIPD, HDLCQ11. Entrez Protein: NP_000228. It is expressed in heart, muscle, and adipose tissue. LPL functions as a homodimer, and has the dual functions of triglyceride hydrolase and ligand/bridging factor for receptor-mediated lipoprotein uptake. Severe mutations that cause LPL deficiency result in type I hyperlipoproteinemia, while less extreme mutations in LPL are linked to many disorders of lipoprotein metabolism.
Immunogen: Purified recombinant fragment of LPL expressed in E Coli. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing LPL are readily searchable from our website. Different antibodies against the same target such as LPL may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. Arteriosclerosis, Atherosclerosis, Cardiovascular Diseases, Diabetes Mellitus, Dyslipidemias, Fatty Liver, Hyperlipidemias, Hypertriglyceridemia, Neoplasms, Obesity are some of the diseases may be linked to Anti-LPL Mouse mAb. LPL also interacts with the following gene(s): APOC2, CETP, LRP1, VLDLR. Adipose Tissue, Blood, Bone, Connective Tissue, Heart, Intestine, Kidney, Liver, Muscle, Vascular tissues are correlated with this protein. The following patways have been known to be associated with this gene.